Angiotech Pharma (ANPI) CEO Hunter Buys 49.5K Shares
More News related to ANPI
- Angiotech Pharmaceuticals, Inc. announces financial results for the third quarter ended September 30, 2009
- Trading Radar for 11/09: Dish Network (DISH), Rockwell (ROK), Priceline.com (PCLN), MBIA (MBI), Ticketmaster (TKTM) Report
- Angiotech Pharmaceuticals announces commercial launch of the Tan Endoglide(TM) Endothelium Insertion System in the United States at the American Academy of Ophthalmology annual meeting
- Angiotech Pharmaceuticals (ANPI) Receives FDA Letter Regarding 510k Submission of Bio-Seal
- Angiotech Pharmaceuticals provides update on Bio-Seal(TM) 510(K) submission
Angiotech Pharmaceutical (Nasdaq: ANPI) President and CEO, William Hunter, purchased 49,500 shares on 9/29 at prices ranging from $1.89-$1.91, bringing his stake to 5,898,091 shares.
Mr. Hunter is the largest shareholder in Angiotech.
Related Categories
Insider TradesStocks Mentioned
+0.01Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
